Inside the research

CONMED Corporation

CNMD Research profile · latest available data

Price overview

$45.38

▲ +0.20 (+0.4%)

52w hi$51.86
52w lo$32.11
Vol282.60K
As of25 Sep 2026

The Verdict

Hold

Our score +0.37

Short+0.31
Medium+0.48
Long+0.27

computed 2026-09-27

Key fundamentals

CONMED Corporation

Healthcare · Medical Devices

Market cap$1.36B
Enterprise value$2.16B
Trailing P/E24.80x
Forward P/E9.49x
EV / EBITDA9.48x
P / S (ttm)0.99x
Profit margin4.1%
Return on equity5.5%
Revenue growth+0.3%
Earnings growth+11.2%
Debt / equity80.11

Layer Breakdown

LayerRawContribution
Fundamental+0.20
Sector+0.08
Technical+0.25
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-09-27

Business overview

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries. It also provides battery-powered, autoclavable, large, and small bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under the Hall surgical brand name. In addition, the company offers general surgery products, such as clinical insufflation systems under the AirSeal brand; smoke removal devices under the Buffalo Filter brand; endomechanical products, including the Anchor1 line of tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors, used in minimally invasive surgeries; and electrosurgical solution comprise monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems, and other accessories. Further, it provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products to treat diseases of dilation, hemostasis, biliary, stricture management, infection prevention, and patient monitoring include ECG electrodes, EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.

United States · www.conmed.com

Risk Metrics

Beta vs SPX0.93
Corr SPX0.34
Annual vol43.9%
Annual ret-15.8%
Sharpe-0.36
Max DD-58.6%

Window: 504 trading days (504 obs)

Material Events

DateEvent8-K
2026-07-29Earnings Release, Exhibitsread
2026-06-17Officer / Director Change, Reg FD Disclosure…read
2026-06-04Material Agreement, Exhibitsread
2026-06-01Material Agreement, Material Obligation…read
2026-05-20Officer / Director Change, Bylaws Amendment…read
2026-04-29Earnings Release, Exhibitsread
2026-03-13Officer / Director Changeread
2026-01-28Earnings Release, Exhibitsread
2026-01-12Reg FD Disclosure, Exhibitsread
2026-01-08Officer / Director Change, Exhibitsread
2025-12-05Reg FD Disclosure, Exhibitsread
2025-11-05Earnings Release, Exhibitsread

Insider Trades

DateInsiderRoleActionSharesValue
2026-06-02Bronson David M.Option exercise668—
2026-06-02Council LaVerne HOption exercise668—
2026-06-02Farkas CharlesOption exercise668—
2026-06-02Kaye MarkOption exercise668—
2026-06-02Schwarzentraub Barbara JOption exercise668—

Flow & Concentration

Insider 180d net$0
Insider buys / sells0 / 0
Insider biasNeutral
13F holders7
Top-5 share100.0%
HHI5,368 (concentrated)

Top Holders

HolderValueShares
State Street Corp$46.39M1.42M
AQR Capital Management$9.19M280.92K
Citadel Advisors$4.86M148.56K
Millennium Management$3.75M114.61K
Fidelity / FMR LLC$898.25K27.44K
Capital Research / Capital World$1.95K2.00K
T. Rowe Price Group$1.47K44.89K

As of 2026-06-30

SEC Filings

DateFormDoc
2026-07-298-Kview
2026-07-2910-Qview
2026-07-173view
2026-07-174view
2026-07-024view
2026-07-023view
2026-07-024view
2026-07-023view
2026-06-178-Kview
2026-06-1611-Kview
2026-06-048-Kview
2026-06-034view
2026-06-034view
2026-06-034view
2026-06-034view

The Long Run

FY 2011–2025 · 15 years

LineLatestCAGRTrend
Revenue$1.37B+4.7%
Gross profit$676.25M+15.6%
Operating income$200.33M+9.4%
Net income$132.42M+23.8%
Cash from ops$125.35M+12.2%

Indices

S&P SmallCap 600

Recent Sessions

DateOpenHighLowCloseVol
Sep 25$45.30$46.51$45.10$45.38282.60K
Sep 24$45.59$45.95$44.79$45.18263.30K
Sep 23$45.48$46.15$44.75$45.80491.20K
Sep 22$45.37$46.55$45.22$46.17441.80K
Sep 21$45.82$45.83$44.39$44.69354.70K

Understand the score. Research layers are inputs to a model, and the available data has limits.

Read the methodology →